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Objective.	The aim of this study wa. to examine the distribution of endothelin-1 (ET-1) in the human placenta a. different gestational ages and to determine whether differences in ET-1 immunoreactivit. occurred in preeclamptic compared with uncomplicated pregnancies.
Methods.	Localization of ET-1 wa. investigated by the immunoperoxidase technique in first-trimester, second-trimester, and term human placentas from normal pregnancies and in placentas from preeclampti. pregnancies.
Results.	In normal placentas fro. all gestational ages studied, endothelin-1 immunoreactivity (ET-1 IR) wa. specifically detected in the endothelium of the fetal vessels and in the syncytiotrophoblast. ET-1 IR was also expressed by the villous cytotrophoblast of first- and second-trimeste. normal placentas. The extravillous cytotrophoblast of the basal and chorioni. plates also exhibited ET-1 IR, but with varying degrees of intensity. In preeclampti. placentas, the expression of ET-1 IR was uneven with a negative staining i. all placentas from pregnancies between the 29th and 32nd weeks of gestation. The expression of ET-1 IR was most intense in some syncytiotrophoblast tissu. in the terminal villi after the 33rd week of gestation. In placentas fro. preeclamptic pregnancies between the 35th and the 36th weeks of gestation, strong ET-1 IR expression was evident in the endothelium of fetal vessel. and in the syncytiotrophoblast. Regardless of gestational age, ET-1 IR wa. also observed in the extravillous cytotrophoblast of the basal and chorioni. plates of preeclamptic placentas.
Conclusion.	This study demonstrate. that ET-1 IR is widely distributed in the human placenta and provides furthe. evidence to support the concept that ET-1 plays an important role as a modulato. of vascular tone in the uteroplacental and fetoplacental units and may participat. in the pathogenesis of preeclampsia.
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INTRODUCTION
The endothelins are a family of regulatory peptides that exert poten. physiological effects on the blood vessels. Endothelin-1 (ET-1), the firs. described member of the family, is a 21-amino-acid peptide isolated from cultur. porcine endothelial cells and is the most potent vasoconstrictor known [1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-1​)]. ET-1 is secreted by a wide variety of tissues, includin. the human amnion and the human placenta [2 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-2​)], suggesting that ET-1 may display a diversity of biological effects in th. human fetoplacental circulation [3 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-3​)].
In the human term placenta, immunocytochemical studies showed ET-1 immunoreactivity (ET-1 IR) localized in the endothelium of fetal vessels, the syncytiotrophoblast, the extravillous cytotrophoblast of the basal, and chorionic plate and als. in the placental septa [4 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-4​), 5 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-5​), 6 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-6​), 7 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-7​), 8 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-8​)]. In addition, cultures of trophoblast cells from human placentas of term pregnancie. have been shown to release ET-1 [9 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-9​)] and expres. endothelin precursor genes [10 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-10​)]. Also, ET-1 mRNA has been observed in human term placentas and in human placentas at 14 and 17 weeks of gestation, although the levels of the mRNA at 14 and 17 week. appear to be low [11 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-11​)].
Preeclampsia, a pregnancy-specific syndrome of still undefined etiology, is an important cause of fetal and maternal mortality and morbidity. Becaus. ET-1 is the most potent vasoconstrictor known today and there are change. in the ET system of term trophoblast in preeclampsia [12 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-12​)], this peptide is likely to play a role in the pathogenesis of hypertension. Several authors have reported increased concentrations of ET-1 in the plasm. of women with preeclampsia as opposed to healthy pregnant women [13 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-13​), 14 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-14​), 15 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-15​)], whereas others could not confir. these findings [16 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-16​)]. However, it seems tha. the balance of evidence is in favor of increased concentrations of ET-1 i. maternal plasma in preeclampsia [17 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-17​)].
Because of the difficulty in obtaining fresh tissues from all stage. of gestation, there is little information about the expression of endothelin-1 in the human placenta during pregnancy. Therefore, one aim of the presen. study was to localize ET-1 in human placental sections of different norma. gestational ages by immuno-cytochemical methods. The purpose of our researc. project was also to investigate by immunocytochemistry the localization o. ET-1 in placental sections from preeclamptic pregnancies. Finally, we als. intended to compare the ET-1 IR observed in the human placentas of hypertensiv. pregnant women with those of normal pregnant women.

MATERIALS AND METHODS
Human placental tissue from 27 normal pregnancies was collected fro. women at 7, 9, 12, 16, 19, 22 (6 placentas), 29 to 32, (8 placentas) 33 to 36, (8 placentas), and 38 to 40 (5 placentas) weeks of gestation. Specimen. from the first and second trimesters were obtained at interruption of pregnanc. or preterm delivery, whereas term ones were obtained from uncomplicated pregnancie. immediately after vaginal delivery or cesarean section. Preterm deliverie. were either for unknown reasons (psychosocial factors) or cervical incompetence, cervical dilatation, and maternal genital abnormalities. All these pregnan. women had normal blood pressure, without proteinuria, intrauterine growt. retardation, or chorioamnionitis. In addition, placental tissues were collecte. from preeclamptic gestations at 29 to 32 (8 placentas) and 33 to 36 weeks (8 placentas) after vaginal delivery or cesarean section. Women classifie. as preeclamptic displayed the following characteristics: development of hypertension, blood pressures after 20 weeks of gestation > 140/90 mm Hg, edema, and proteinuri. of > 0.5 g/24 h or  3 + on dip-stick testing, where delivery preclude. a 24 h urine collection.
The first-trimester specimens were small and did not require any furthe. processing. Representative areas of third-trimester placentas were first cu. into small pieces (2 × 2 × 2 cm). They were then immediately immerse. in a 4% formaldehyde solution in a 0.1M phosphate buffer at pH = 7.3, fixed for 20 h at +4°C, and finally processe. for paraffin wax embedding. Additional tissue specimens excised from the basa. and chorionic plates were similarly fixed and embedded in paraffin. In eac. case, the interval between delivery and fixation was  3 min. Four-micrometer-thic. sections were cut and mounted on poly-L-lysine-coate. glass slides and dewaxed by standard techniques for the immunocytochemica. experiments.
To determine the localization of ET-1 IR, an immunocytochemical techniqu. was applied using an avidin–biotin–peroxidase complex (ABC) method. Tissues from normal and preeclamptic placentas were tested on the same ru. so as to allow identification of age-related and gestation-related difference. in the signal of immunoreactivity. The slides with sections were immerse. in methanol containing 0.6% hydrogen peroxide for 30 min to suppress endogenou. peroxidase activity. This was followed by washing them in phosphate buffere. saline (PBS) with a pH of 7.3. After the blocking of nonspecific backgroun. staining with normal swine serum diluted 1 : 5 plus 1% bovine serum albumin (BSA) in PBS for 20 min at room temperature, sections were blotted to remov. excess serum and incubated overnight in a moist chamber at +4°C with rabbi. antiserum to human ET-1 (IHC-6901 Peninsula Laboratories, Inc., Belmont, CA. at a dilution of 1 : 500 with 1% BSA in PBS. The preparations were then rinse. with PBS and incubated for 30 min with biotinylated swine anti-rabbit immunoglobulin. at a dilution of 1 : 300 in PBS : BSA followed, after washing in PBS, by incubatio. for 60 min with the ABC complex freshly prepared (diluted 1 : 200). The site. of peroxidase activity were revealed with 0.06% of 3,3'-diaminobenzidin. containing 0.01% of hydrogen peroxide in PBS for 2 min. After the final washing, sections were counterstained with Harris hematoxilin, dehydrated, cleare. in xylene, and mounted in DPX (BDH Laboratory Supplies).
To ensure the identification of the extravillous cytotrophoblast (EVT), we proceeded to the immunocytochemical detection of human placental lactogen (hPL) with a rabbit anti-human placental lactogen antiserum (Dako A/S, Cod. No. A 137).
To guarantee the specificity of the immunologic reactions, adjacen. control sections were subjected to the same method, except that the primar. antibody was replaced by nonimmune immunoglobulin G or used after being preabsorbe. with 15 µM of ET-1 (6901 Peninsula Laboratories, Inc., Belmont, CA). The immunocytochemical detection of ET-1 was performe. in three tissue specimens for each placenta and in six tissue sections fo. each specimen.
Statistical Analysis
An immunostaining score according to the graduated intensities of th. reaction product was defined and scored blindly by one observer in a five-step (−, +, ++, +++, ++++) grading system. The semiquantitative score value. of the two groups (preeclampsia and normal) were compared with one anothe. by using the Mann–Whitney U-test (StatView 5.0.1 software). A p-value < 0.05 was considered significant.

RESULTS
The distribution of ET-1 IR was examined in normal human placentas an. in placentas from preeclamptic pregnancies. ET-1 IR was clearly demonstrate. and its localization was similar in sections of all placentas. There was n. difference in ET-1 expression between placentas from vaginal and cesarea. section deliveries.
In all the gestational ages studied, ET-1 IR was observed in the endotheliu. of blood vessels localized in the mesoderm of normal placental villi as show. in (Figs. 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0001#F0001​)A and 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0001#F0001​)B). Although immunostaining was present in virtually all endothelium vessels, a considerable variation in the intensity of staining was noticed, wherea. in some villi, no reaction product was found in the endothelial cells.
	Figure 1 Immunocytochemical localization of ET-1 in normal huma. placentas. Placental villi demonstrating a difuse ET-1 IR in the syncytiotrophoblasts (S) and in the endothelial cells (arrow heads) of the fetal blood vessel. at 22 (A) and 33 (B) weeks of gestation. The EVT in the basal plate show. an intense immunoreactivity at 38 (C) weeks of gestation, while the cytotrophoblas. in the chorionic plate reveals a weak immunoreactivity (D).[Medium View]
[Enlarged View]
In all normal placental tissues, the syncytiotrophoblast layer of th. chorionic villi exhibited an intense and diffusely homogeneous distributio. of cytoplasmic immunoreactivity for ET-1 (Figs. 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0001#F0001​)A and 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0001#F0001​)B). A positive immunostaining was observe. in the cytotrophoblast cells within the villi of first- and second-trimeste. normal placentas. Because of the paucity of cytotrophoblast cells within th. villi of term placentas, we were unable to determine for sure whether ET-1 IR was present in cytotrophoblast from term placentas. In the basal plat. of second-trimester and term placentas, there are polygonal or round cell. that are immunostained for hPL (data not shown), from which we can conclud. that they are extravillous cytotrophoblast (EVT) [18 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-18​), 19 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-19​), 20 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-20​)]. These cells expressed ET-1 IR with various degrees of intensity (Fig. 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0001#F0001​)C). Faint ET-1 IR was observed in the cytotrophoblast localize. in the chorionic plate of normal placentas regardless of gestational age (Fig. 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0001#F0001​)D).
The immunocytochemical detection of ET-1 performed on sections of preeclampti. placental fragments revealed a heterogeneous expression of the ET-1 IR. Stainin. was negative or detachable only in some syncytiotrophoblasts and endothelia. cells of fetal vessels of placentas from preeclamptic pregnancies betwee. the 29th and 32nd weeks of gestation (Fig, 2 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0002#F0002​)A). Staining was more variable in some syncytiotrophoblasts of the smaller vill. of placental tissue samples from patients with preeclampsia at the 33rd wee. of gestation (Fig 2 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0002#F0002​))B.
	Figure 2 Photomicrographs showing ET-1-like immunostaining in section. of human placentas from preeclamptic pregnancies. Notice that the trophoblasti. layers (T) and the endothelial cells (arrow heads) of the fetal blood vessel. are negative for ET-1 IR at 32 (A) weeks of gestation, whereas the syncytiotrophoblast (S) and the endothelial cells (arrow heads) reveal a weak reaction at 33 week. of gestation (B) and a stronger immunoreactivity at 36 weeks of gestation (C). The immunoreactivity of all positive cells was completely abolished whe. primary antiserum was substituted by nonimmune serum (D).[Medium View]
[Enlarged View]
A more intense immunoreactivity was evident in the endothelium of feta. vessels of stem villi. Syncytiotrophoblast was positive mainly in the termina. villi of placental tissue samples from preeclamptic pregnancies between the 35th and the 36th week of gestation (Fig. 2 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0002#F0002​)C). At light microscopic level, the difference observed in the immunocytochemica. staining pattern between normal and preeclamptic placentas was very consisten. at 29 to 32 weeks and 33 to 36 weeks (Table 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "T0001#T0001​)).
Table 1 Semiquantitative Analysis of Immunostaining
	29–32 Weeks	33–36 Weeks
	N (8 Placentas)	P (8 Placentas)	Significance	N (8 Placentas)	P (8 Placentas)	Significance

Note: The range score (+ to 4+) refers to the presence and relative abundance of expression. (—) = no. detectable; (+ / −) = detectable in some cells only; (+)=low level o. expression; (2+ to 3+) = moderate to strong; (4+) = abundant expression. Mann–Whitney U-test. Significance with p value <0.05. Range score and median for each cell type. EVT, extravillou. cytotrophoblast; N, normal placentas; P, preeclamptic placentas.						
Endothelium	—/2+	—/1+	P < 0.05	—/2+	—/2+	NS
	(Median 1+)	(Median 1+)		(Median 1+)	(Median 1+)	
Syncytiotrophoblast	3 +/4+	—/1+	p < 0.001	3 +/4+	2 +/3+	p < 0.001
	(Median 4+)	(Median 1+)		(Median 4+)	(Median 2+)	
EVT	3+/4+	3+/4+	NS	3+/4+	3+/4+	NS
	(Median 3+)	(Median 3+)		(Median 3.5+)	(Median 3+)	

In all placental tissue samples from basal and chorionic plates of placenta. from preeclamptic pregnancies, a strong ET-1 IR signal was observed in th. EVT regardless of gestational age. Although some variation in the immunoreactivit. to ET-1 was evident in the EVT from normal and preeclamptic placentas, n. obvious difference was observed between the two groups (Table 1 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "T0001#T0001​)). The staining was specific for endothelin because immunostaining was absen. in the placental villi, basal plate, and chorionic plate, when primary antiseru. was substituted by nonimmune serum or preabsorbed with ET-1 (Fig. 2 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​ss3.htm" \l "F0002#F0002​)D).
DISCUSSION
In this study, we have investigated the immunocytochemical localizatio. of ET-1 in first-trimester, second-trimester, and term human placentas fro. normal pregnancies and from some preeclamptic gestations. ET-1 IR was presen. in the endothelial cells lining the fetal capillaries of normal placenta. villi at all gestational ages studied. A similar pattern of staining of placenta. endothelium was demonstrated in an earlier report but only in term placentas [6 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-6​)]. This study shows that ET-1 IR is als. present in first- and second-trimester placentas. This suggests that the presenc. of ET-1 in the placenta early in pregnancy probably contributes alone or i. synergy with growth factors to placental development [21 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-21​)]. In human placenta, ET-1 is present at as early a stage as 7 weeks of gestation. No visible differences in intensity of ET-1 IR were observed in the norma. placental group between weeks 7 and 22. However, given the small number o. placentas in this group, we cannot exclude a significant variation in ET-1 expression within the aforementioned period of gestation.
In some fetal vessels, the endothelial cells show an ET-1 IR response, whereas sometimes in adjacent villi, no positive immunostaining was observed. This fact was also reported by other researchers with no explanation for thi. observation [5 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-5​), 7 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-7​)]. Little is know. about the mechanisms through which endothelin is released from the endothelia. cells. Relying on electron microscopic observation of ET-1 in the cytoplasm, Nakamura et al. [22 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-22​)] suggested that endotheli. is secreted by the constitutive pathway without prior concentration and storag. in secretory granules. Endothelin may then be rapidly released from the cell, which explains the lack of immunostaining observed in some endothelial cells. The expression of endothelin in blood vessels is not universal and may b. a regulated process, as suggested by studies in other organs in which immunostainin. for ET-1 in the vascular endothelium is focal [23 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-23​)], as is the distribution of ET-1 mRNA [24 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-24​)].
Our results show ET-1 immunostaining in the syncytiotrophoblast of norma. villi at all the gestational ages studied. In the first-trimester placentas, the villous cytotrophoblast reveals the presence of ET-1 IR. Because of th. paucity of cytotrophoblast cells within the villi of term placentas, we wer. unable to determine for sure whether ET-1 IR was present in cytotrophoblas. from term placentas. In the EVT of the basal and chorionic plates, ET-1 I. was detected in second-trimester and term placentas.
The present study demonstrates the presence of ET-1 IR in villous an. nonvillous trophoblast, in agreement with some studies [7 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-7​)] but in disagreement with others [4 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-4​), 5 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-5​), 6 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-6​)]. According to Malassiné et al. [7 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-7​)], this discrepancy is most likely a result of different methods. In fact, althoug. the ET-1 antibody used was the same—instead of van Papendorp’s et al. [5 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-5​)] and Hemsén’s et al. [4 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-4​)] buffered formalin solution—th. specimens used by Malassiné et al. [7 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-7​)] were fixed by immersion in Bouin solution. Also, his antibody complex wa. visualized by the sensitive ABC procedure instead of peroxidase–antiperoxidase [5 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-5​)] or rhodamine-conjugated second antibody [4 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-4​)].
Wilkes et al. [6 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-6​)] observed a patter. of distribution of ET-1-like immunoreactivity similar to the reports of va. Papendorp et al. [5 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-5​)] and Hemsén e. al. [4 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-4​)]. However, the sections were incubate. in trypsin in both cases, and given the inability of the antibody to distinguis. between ET-1 and big ET-1, it was impossible to determine which isoform wa. detected. Although in the present study the ET-1 antibody and the ABC metho. to visualize the antibody complex were the same used by Malassiné e. al. [7 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-7​)], the specimens were fixed by immersio. in buffered formalin solution similar to methods used by Wilkes et al. [6 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-6​)].
The nonvillous trophoblast is a particular invasive cell populatio. that exerts its effects and its invasiveness by a hitherto insufficientl. and poorly defined mechanism. ET-1 secreted by EVT could act as an autacoid, which stimulates stimulating cellular invasion [25 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-25​)] and controls both maternal and fetal circulation during pregnancy and labor [26 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-26​)]. The possible secretion of ET-1 by th. trophoblast of normal placentas may serve as an important extravascular sourc. for various biological actions, such as growth factor activity during th. proliferation and differentiation of the various cellular populations of th. placenta [21 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-21​), 27 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-27​)].
The results of the immunocytochemical localization of ET-1 in placenta. sections from preeclamptic pregnancies were partially unexpected. In fact, a heterogeneous expression of ET-1 in the syncytiotrophoblast and a marke. immunoreactivity in the EVT were observed. In many sections, the syncytiotrophoblas. and the endothelial cells of the fetal blood vessels show a weak or even nonexisten. ET-1 staining. However, in some sections, the same cells show positive stainin. with an equal intensity to that observed in placentas from normal pregnancies.
Close analysis of these results shows clearly that weak or absent immunostainin. of the syncytiotrophoblast was observed in sections of placentas from preter. pregnancies with severe preeclampsia. By contrast, the sections where th. ET-1 staining was stronger came from pregnancies with not such serious preeclampsia. The source of ET-1 in placental cells might also result from sequestratio. by binding. In fact, maximum binding of ET-1 to placental membranes is lowe. in preeclamptic pregnancies, compared with preterm normal controls attributabl. to the presence of fewer receptors [28 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-28​)]. However, specific binding of ET-1 to trophoblast cell membranes from preeclampti. pregnancies is already higher in preterm compared with normal controls [28 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-28​)]. Thus, the opposite changes in ET-1 binding associate. with preeclampsia in the endothelium and trophoblast may not explain the les. intensive immunostaining observed in these placentas.
The different intensity of the immunocytochemical reaction observe. between the syncytiotrophoblast from normal and preeclamptic placentas suggest. the presence of distinct concentrations of ET-1 in these cells. This doe. not support the suggestion that the increased plasma endothelin levels i. preeclamptic women [14 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-14​), 15 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-15​), 29 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-29​)] may have, at least partially, a trophoblastic origin.
The mechanism of plasma endothelin elevation in preeclampsia is, s. far, unknown, but it may be the result of an abnormal synthesis or releas. of ET-1 by injured endothelial cells [30 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-30​), 31 (​http:​/​​/​taylorandfrancis.metapress.com​/​media​/​988t62jmek4jtj894u5m​/​contributions​/​x​/​8​/​t​/​m​/​x8tmug9lem2v73hv_html​/​bib.htm" \l "cit4179-31​)] with disruption of the endothelial/muscular fiber complex and leakage of endotheli. from its local environment to the bloodstream. Nevertheless, a trophoblasti. origin of endothelin cannot be excluded—whereby an increased diffusio. into the maternal circulation would contribute to the elevated levels of ET-1—thu. explaining the weak positive immunostaining observed in the syncytiotrophoblast.
In this study, and contrary to the syncytiotrophoblast, the EVT fro. preeclamptic placentas shows a strong ET-1 immunostaining. As in the villou. trophoblast, the source of ET-1 in the EVT could be attributable to sequestratio. by binding or through local synthesis. However, nothing is known about th. presence of ET-1 receptors in these cells.
In conclusion, trophoblastic hyperplasia is the most obvious morphologica. alteration of the placenta in preeclamptic pregnancy. Because the number o. trophoblasts exceeds that of any other cell type in the placenta, productio. of ET-1 by trophoblasts may contribute to the regulation of vascular ton. and participate in the pathogenesis of preeclampsia and related disorders, such as intrauterine growth retardation. At the same time, because endothelia. cell dysfunction and probably syncytiotrophoblast alterations are characteristi. features of preeclampsia, endothelial-cell and syncytiotrophoblast-derive. substances, such as endothelin, may play a central role in the pathophysiolog. of this condition. Additional studies in this field should be conducted.
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